Finch Therapeutics(FNCH)
BOSTON, MABiotechnology
Focus: Finch Therapeutics is a public microbiome-focused biotech company developing live biotherapeutic products (LBPs) for infectious disease and neuropsychiatric indications. The company operates in an emerging therapeutic area with limited commercial scale.
Profile data last refreshed 6h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Total Funding
$90M
Open Jobs
11+2 this month
Stable — net +2 jobs in 30d
5 added, 3 removed. Backfill posture.
Should You Work at Finch Therapeutics?
AI assessmentHigh-risk, high-reward opportunity suited for early-stage biotech specialists willing to bet on microbiome science and accept meaningful financial volatility.
Why Work Here
- Exposure to novel microbiome therapeutics modality with multiple Phase 2/3 programs in clinical development
- Public company status provides equity upside potential and public market validation
Data completeness
3/9 — Basic
Company HealthStrong
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$861K
Pipeline & Clinical Trials
Physical examination
Anal Intraepithelial NeoplasiaClinical Trials (1)
NCT05858021COrSIcA: Disease Measurement
N/AHelp build intelligence for Finch Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.